Zusammenfassung
Das Adenokarzinom der Prostata ist gegenwärtig mit annähernd 100000 Neuerkrankungen pro Jahr und 30000 Todesfällen der am weitesten verbreitete Krebs unter amerikanischen Männern. Durch eine Änderung des Konzeptes der chirurgischen Behandlung bei dieser Erkrankung sind bis zu 30% der am Prostatakarzinom erkrankten Patienten potentielle Kanditaten für eine definitive Operation, wie z. B. die radikale Prostatektomie.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Whitmore WF jr (1987) Long-term effects of initial therapy. Cancer 60 [Suppl] 3: 559–562
Kuban DA, El-Mandi AM, Schellhammer PF (1987) Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma. Urology 30: 420–426
Zincke H, Utz DC, Thule PM, Taylor WF (1987) Treatment options for patients with stage D1 (T0–3, N1–2, MO) adenocarcinoma of prostate. Urology 30: 307–315
Bagshaw MA, Ray GR, Cox RS (1985) Radiotherapy of prostatic carcinoma: Long-or short-term efficacy (Stanford University experience). Urology 25 [Suppl] 2: 17–23
Zincke H, Fleming TR, Furlow WL, Myers RP, Utz DC (1981) Radical retropubic prostatectomy and pelvic lymphadenectomy for highstage cancer of the prostate. Cancer 47: 1901–1910
Zincke H, Utz DC (1983) Radical surgery for stage D 1 prostate cancer. Semin Urol 1: 253–260
Bagshaw MA (1985) Potential for radiotherapy alone in prostatic cancer. Cancer 55 [Suppl] 9: 2079–2085
Zincke H, Utz DC, Taylor WF (1986) Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J Urol 135: 1199–1205
Brayhack JT, Keeler TC, Kozlowski JM (1984) Carcinoma of the prostate. Hormonal therapy. Cancer 60 [Suppl] 3: 589–601
Isaacs JT (1984) The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer. Prostate 5: 1–17
Winkler HZ, Rainwater LM, Myers RP, Far GM, Therneau TM, Zincke H, Lieber MM (1988) D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 63: 103–112
Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffinembedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333–1335
Vindelov LL, Christensen IJ, Nissen NI (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323–327
Winkler HZ, Rainwater LM, Myers RP, Zincke H, Farrow GM, Therneau TM, Lieber MM (1988) Prognostic significance of DNA ploidy and early endocrine therapy in stage D1 prostate cancer (abstract). Annual meeting of the American Urological Association, Boston, Massachusetts, June 3 to 7
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Benson, R.C., Zincke, H. (1990). Radikale Prostatektomie beim Prostatakarzinom im Stadium D1 (T0–3, N1–2, M0). In: Frohmüller, H.G.W., Wirth, M.P. (eds) Behandlung des fortgeschrittenen Prostatakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84064-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-84064-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52076-4
Online ISBN: 978-3-642-84064-7
eBook Packages: Springer Book Archive